Gastric
cancer is one of the five most fatal types of cancer. According to the
statistics of the World Health Organization (WHO), about 750,000 patients die
each year after developing the disease. The main cause is thought to be the
bacterium Helicobacter pylori (H. pylori). At present, there are no effective
therapies for gastric cancer and growing spread of antibiotic resistances is
further complicating treatment of the infection. Researchers at
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have now identified two
mechanisms through which this bacterium can cause gastric cancer. Their
findings could result in the development of new therapeutic approaches.
The
international team of scientists headed by Dr. Nicole Tegtmeyer of the Chair of
Microbiology at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
investigated how bacteria destroy the stomach's protective layer. This protective
layer is composed of densely packed epithelial cells that protect the stomach
against the effects of gastric acid. The researchers have now discovered that
H. pylori secretes an enzyme, a protease called HtrA, which it uses much like a
weapon to penetrate this protective layer. HtrA cleaves the three proteins
occludin, claudin-8 and E-cadherin, rupturing the layer of epithelial cells. As
a result, the H. pylori bacteria can access deeper, normally pathogen-free
tissue layers, and inflict further damage. This is the first step towards
gastric cancer starting to develop.
This
first phase, however, is followed by one that is even more dangerous, as the
team discovered. Needle-like protrusions, termed type IV secretion systems, are
activated and function as 'molecular syringes'. Using a receptor-dependent
mechanism, these inject a bacterial toxin, the CagA protein, through the
basolateral membrane of the host cells. The injected CagA subsequently
reprograms host cells, making them potentially cancerous. Another effect of
this protein is that it prevents the human immune system from recognising and
eliminating the bacteria -- a crucial mechanism for the long-term survival of
H. pylori in the human stomach.
See:
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources